Abcam and the other 17 members of the partnership today launched the IHI project, LIGAND-AI, to advance AI-driven drug ...

UCL joins global €60m AI-driven drug discovery initiative to generate open datasets and accelerate new medicines using AI models ...

The "Optical Genome Mapping Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been ...

A new global public-private partnership using artificial intelligence (AI) to accelerate drug discovery is launching with UCL as one of the lead ...

Oregon State University researchers have painted a clearer picture of the coastal marten, a secretive, ferret-sized forest carnivore renowned for its cuteness but nearly driven to extinction by human ...

This important study, which tackles the challenge of analyzing genome integrity and instability in unicellular pathogens by introducing a novel single-cell genomics approach, presents compelling ...

According to Nova One Advisor, the global next-generation sequencing market size is calculated at USD 17.37 billion in 2026 ...

Structural variations (SVs), including insertions, deletions, inversions, and substitutions, can profoundly influence gene regulation and phenotype.

High-resolution analytical platforms, proteomics-driven workflows, and expanding CRO outsourcing reshape strategic priorities ...

Artificial intelligence (AI) is transforming the life sciences industry, with potentially its most significant impact on drug ...

How AI, robotics, and modular design are transforming single-cell and spatial biology into scalable, precision-driven engines of discovery.

Machine learning models are designed to analyze large, heterogeneous datasets and identify complex relationships without ...